# LOTEPREDNOL ETABONATE

NDC: 0574-4135
Generic name: loteprednol etabonate
Labeler / Manufacturer: Padagis US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20260112

FDA application: ANDA215204

## Active ingredients

- LOTEPREDNOL ETABONATE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0574-4135"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0574-4135
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55ec893d-4955-4d2c-8b5b-84f462d23e02